ZA936306B - Imidazolidine derivatives - Google Patents
Imidazolidine derivativesInfo
- Publication number
- ZA936306B ZA936306B ZA936306A ZA936306A ZA936306B ZA 936306 B ZA936306 B ZA 936306B ZA 936306 A ZA936306 A ZA 936306A ZA 936306 A ZA936306 A ZA 936306A ZA 936306 B ZA936306 B ZA 936306B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazolidine derivatives
- metastasis
- inhibitors
- stated
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Fats And Perfumes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4228717A DE4228717A1 (de) | 1992-08-28 | 1992-08-28 | Imidazolidin-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA936306B true ZA936306B (en) | 1994-03-22 |
Family
ID=6466684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA936306A ZA936306B (en) | 1992-08-28 | 1993-08-27 | Imidazolidine derivatives |
Country Status (16)
Country | Link |
---|---|
US (1) | US5554594A (da) |
EP (1) | EP0584694B1 (da) |
JP (1) | JP3578472B2 (da) |
KR (1) | KR100405117B1 (da) |
AT (1) | ATE162531T1 (da) |
AU (1) | AU663213B2 (da) |
CA (1) | CA2105014C (da) |
CZ (1) | CZ289077B6 (da) |
DE (2) | DE4228717A1 (da) |
DK (1) | DK0584694T3 (da) |
ES (1) | ES2112361T3 (da) |
HU (1) | HUT65552A (da) |
IL (1) | IL106821A0 (da) |
SK (1) | SK282518B6 (da) |
TW (1) | TW303361B (da) |
ZA (1) | ZA936306B (da) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821372A (en) * | 1995-11-28 | 1998-10-13 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
TW418195B (en) * | 1995-11-28 | 2001-01-11 | American Home Prod | 2-thioxo-imidazolidin-4-one derivatives |
US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
US5599829A (en) * | 1995-11-28 | 1997-02-04 | American Home Products Corporation | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels |
DK0796855T3 (da) | 1996-03-20 | 2002-05-27 | Hoechst Ag | Hæmmere af knogleresorption og vitronectin-receptorantagonister |
DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
US5663363A (en) * | 1996-11-21 | 1997-09-02 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5861517A (en) * | 1996-11-21 | 1999-01-19 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
EP0983095B1 (de) * | 1997-05-22 | 2004-09-29 | Biomet Deutschland GmbH | Peptid-beschichtete implantate und verfahren zu ihrer herstellung |
RU2141483C1 (ru) * | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6187924B1 (en) * | 1997-11-12 | 2001-02-13 | Darwin Discovery, Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
DE19751251A1 (de) | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
DE19821483A1 (de) * | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6723722B1 (en) | 1999-06-22 | 2004-04-20 | Takeda Chemical Industries, Ltd. | Acylhydrazine derivatives, their production and use |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
DE10137595A1 (de) * | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
FR2850652B1 (fr) * | 2003-01-31 | 2008-05-30 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
US7354933B2 (en) | 2003-01-31 | 2008-04-08 | Aventis Pharma Sa | Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
US20060039949A1 (en) * | 2004-08-20 | 2006-02-23 | Nycz Jeffrey H | Acetabular cup with controlled release of an osteoinductive formulation |
US20060045902A1 (en) * | 2004-09-01 | 2006-03-02 | Serbousek Jon C | Polymeric wrap for in vivo delivery of osteoinductive formulations |
US20060057184A1 (en) * | 2004-09-16 | 2006-03-16 | Nycz Jeffrey H | Process to treat avascular necrosis (AVN) with osteoinductive materials |
US9119901B2 (en) * | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US20070077267A1 (en) * | 2005-10-03 | 2007-04-05 | Sdgi Holdings, Inc. | Bioactive composite implants |
US20070179615A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Intervertebral prosthetic disc |
US20070179618A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Intervertebral prosthetic disc |
US20070280986A1 (en) * | 2006-06-01 | 2007-12-06 | Carlos Gil | Intra-operative coating of implants |
US8133553B2 (en) | 2007-06-18 | 2012-03-13 | Zimmer, Inc. | Process for forming a ceramic layer |
US8309521B2 (en) | 2007-06-19 | 2012-11-13 | Zimmer, Inc. | Spacer with a coating thereon for use with an implant device |
US8608049B2 (en) | 2007-10-10 | 2013-12-17 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
WO2009096945A1 (en) * | 2008-01-29 | 2009-08-06 | Zimmer, Inc. | Implant device for use in an implant system |
WO2016172496A1 (en) | 2015-04-23 | 2016-10-27 | Constellation Pharmaceuticals, Inc. | Lsd1 inhibitors and uses thereof |
US11020160B2 (en) | 2016-03-21 | 2021-06-01 | Warsaw Orthopedic, Inc. | Surgical injection system and method |
US10709814B2 (en) | 2016-04-22 | 2020-07-14 | Warsaw Orthopedic, Inc. | Osteoimplant comprising an insoluble fibrous polymer |
JP7142633B2 (ja) | 2016-10-26 | 2022-09-27 | コンステレーション・ファーマシューティカルズ・インコーポレイテッド | Lsd1阻害剤およびその医学的使用 |
GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4009506A1 (de) * | 1990-03-24 | 1991-09-26 | Hoechst Ag | Hydantoinderivate |
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
DE4207254A1 (de) * | 1992-03-07 | 1993-09-09 | Cassella Ag | 4-oxo-2-thioxoimidazolidin-derivate |
DE4213634A1 (de) * | 1992-04-24 | 1993-10-28 | Cassella Ag | 2,4-Dioxo-imidazolidin-Derivate |
-
1992
- 1992-08-28 DE DE4228717A patent/DE4228717A1/de not_active Withdrawn
-
1993
- 1993-07-01 JP JP16303793A patent/JP3578472B2/ja not_active Expired - Fee Related
- 1993-07-24 TW TW082105951A patent/TW303361B/zh active
- 1993-08-17 DK DK93113143T patent/DK0584694T3/da active
- 1993-08-17 ES ES93113143T patent/ES2112361T3/es not_active Expired - Lifetime
- 1993-08-17 DE DE59308021T patent/DE59308021D1/de not_active Expired - Lifetime
- 1993-08-17 AT AT93113143T patent/ATE162531T1/de not_active IP Right Cessation
- 1993-08-17 EP EP93113143A patent/EP0584694B1/de not_active Expired - Lifetime
- 1993-08-25 SK SK909-93A patent/SK282518B6/sk unknown
- 1993-08-25 CZ CZ19931747A patent/CZ289077B6/cs not_active IP Right Cessation
- 1993-08-27 AU AU44914/93A patent/AU663213B2/en not_active Ceased
- 1993-08-27 KR KR1019930016760A patent/KR100405117B1/ko not_active IP Right Cessation
- 1993-08-27 CA CA002105014A patent/CA2105014C/en not_active Expired - Fee Related
- 1993-08-27 ZA ZA936306A patent/ZA936306B/xx unknown
- 1993-08-27 IL IL106821A patent/IL106821A0/xx not_active IP Right Cessation
- 1993-08-27 HU HU9302439A patent/HUT65552A/hu not_active Application Discontinuation
-
1995
- 1995-05-31 US US08/456,066 patent/US5554594A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE59308021D1 (de) | 1998-02-26 |
ES2112361T3 (es) | 1998-04-01 |
SK282518B6 (sk) | 2002-10-08 |
DE4228717A1 (de) | 1994-03-03 |
JP3578472B2 (ja) | 2004-10-20 |
ATE162531T1 (de) | 1998-02-15 |
CA2105014A1 (en) | 1994-03-01 |
HUT65552A (en) | 1994-06-28 |
EP0584694A1 (de) | 1994-03-02 |
IL106821A0 (en) | 1993-12-08 |
JPH0753590A (ja) | 1995-02-28 |
HU9302439D0 (en) | 1993-11-29 |
CA2105014C (en) | 2003-11-25 |
DK0584694T3 (da) | 1998-09-14 |
US5554594A (en) | 1996-09-10 |
AU4491493A (en) | 1994-03-03 |
AU663213B2 (en) | 1995-09-28 |
EP0584694B1 (de) | 1998-01-21 |
KR100405117B1 (ko) | 2004-04-06 |
SK90993A3 (en) | 1994-04-06 |
KR940003939A (ko) | 1994-03-14 |
TW303361B (da) | 1997-04-21 |
CZ174793A3 (en) | 1994-03-16 |
CZ289077B6 (cs) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA936306B (en) | Imidazolidine derivatives | |
AU3820393A (en) | 2,4-dioxoimidazolidine derivatives | |
HU9202583D0 (en) | Hidantoine derivatives | |
ZA937081B (en) | Azaquinoxalines processes for their preparation and their use | |
HU9302335D0 (en) | 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
CA2130174A1 (en) | 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation | |
CA2155843A1 (en) | Novel urea derivatives, their preparation and use | |
BG102553A (en) | Thiol derivatives having metallopeptidase inhibitor activity | |
GR3021303T3 (en) | Benzimidazoles, pharmaceutical compositions containing them and process for their preparation | |
BG98238A (en) | Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides | |
AU558203B2 (en) | 1-hydroxy propyl resorcin derivatives | |
PL312966A1 (en) | Derivatives of thiocarbamoil | |
DE3364038D1 (en) | 5,6-dihydro-11-alkylene-mophantridin-6-ones, process for their preparation and pharmaceutical compositions containing them | |
IL140919A0 (en) | N-substituted azabicycloheptane derivatives, production and use thereof |